Search research articles
Contact Us
Filters
Showing results (1-10 of 56) with videos related to
Page
of 6
Sort By:
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|
August 24, 2007
Fatigue: implications for the elderly
Jeannette Y Wick, Joanne LaFleur
Journal of Pain & Palliative Care Pharmacotherapy
|
September 15, 2004
Methods to measure patient compliance with medication regimens
Joanne LaFleur, Gary M Oderda
Journal of Pain & Palliative Care Pharmacotherapy
|
July 20, 2004
The treatment outcomes of pain survey (TOPS): a clinical monitoring and outcomes instrument for chronic pain practice and research
Mei-Jen Ho, Joanne LaFleur
Clinical Therapeutics
|
March 15, 2011
A review of diabetes treatment adherence and the association with clinical and economic outcomes
Carl Asche, Joanne LaFleur, Chris Conner
Pharmacoeconomics
|
May 7, 2015
Calculating the Baseline Incidence in Patients Without Risk Factors: A Strategy for Economic Evaluation
Scott D Nelson, Daniel Malone, Joanne Lafleur
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 17, 2004
Economic benefits of investigational drug services at an academic institution
Joanne LaFleur, Linda S Tyler, Rajiv R Sharma
Medgenmed : Medscape General Medicine
|
December 20, 2007
Medication nonadherence: an unrecognized cardiovascular risk factor
Mark A Munger, Benjamin W Van Tassell, Joanne LaFleur
The Annals of Pharmacotherapy
|
January 31, 2008
Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature
Joanne LaFleur, Carrie McAdam-Marx, Carmen Kirkness, et al.
Journal of Pain & Palliative Care Pharmacotherapy
|
November 23, 2007
Problems in studying the association between race and pain in outcomes research
Joanne Lafleur, Qayyim Said, Carrie McAdam-Marx, et al.
Pain
|
September 24, 2015
Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine
Brandon K Bellows, Richard E Nelson, Gary M Oderda, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 56) with videos related to
Sort By:
Page
of 6
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists
|
August 24, 2007
Fatigue: implications for the elderly
Jeannette Y Wick, Joanne LaFleur
Journal of Pain & Palliative Care Pharmacotherapy
|
September 15, 2004
Methods to measure patient compliance with medication regimens
Joanne LaFleur, Gary M Oderda
Journal of Pain & Palliative Care Pharmacotherapy
|
July 20, 2004
The treatment outcomes of pain survey (TOPS): a clinical monitoring and outcomes instrument for chronic pain practice and research
Mei-Jen Ho, Joanne LaFleur
Clinical Therapeutics
|
March 15, 2011
A review of diabetes treatment adherence and the association with clinical and economic outcomes
Carl Asche, Joanne LaFleur, Chris Conner
Pharmacoeconomics
|
May 7, 2015
Calculating the Baseline Incidence in Patients Without Risk Factors: A Strategy for Economic Evaluation
Scott D Nelson, Daniel Malone, Joanne Lafleur
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
January 17, 2004
Economic benefits of investigational drug services at an academic institution
Joanne LaFleur, Linda S Tyler, Rajiv R Sharma
Medgenmed : Medscape General Medicine
|
December 20, 2007
Medication nonadherence: an unrecognized cardiovascular risk factor
Mark A Munger, Benjamin W Van Tassell, Joanne LaFleur
The Annals of Pharmacotherapy
|
January 31, 2008
Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature
Joanne LaFleur, Carrie McAdam-Marx, Carmen Kirkness, et al.
Journal of Pain & Palliative Care Pharmacotherapy
|
November 23, 2007
Problems in studying the association between race and pain in outcomes research
Joanne Lafleur, Qayyim Said, Carrie McAdam-Marx, et al.
Pain
|
September 24, 2015
Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine
Brandon K Bellows, Richard E Nelson, Gary M Oderda, et al.
Page
of 6